Company Description: About Novavax Novavax, Inc. (Nasdaq: NVAX), a clinical-stage biopharmaceutical company, employs its cutting-edge technology to create next-generation vaccines to prevent serious infectious diseases, such as pandemic and seasonal influenza and respiratory syncytial virus (RSV). The company’s proprietary virus-like-particle (VLP) technology and single-use bioprocessing system enable rapid vaccine development and production where and when they are needed, worldwide. The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additional information about Novavax is available on the company’s website: www.novavax.com.
9920 Belward Campus Dr Rockville, MD 20850-3991
Industries: Research, Biotechnology, Pharmaceuticals, Startups
Technologies: Novavax, Inc is using 5 Technologies.
Social Media: Novavax, Inc has 65 social media shares and likes.
We have 9 emails for Novavax, Inc.
Verified Contacts from
Web Server Technology
Similar Research Companies
These are contacts we've discovered through publicly available sources and might be outdated.
Use our PerfectLink™ Contact Finder to verify contacts.
Additional Info and Employees
Novavax creates recombinant protein nanoparticle vaccines to address a broad range of infectious diseases.
Sign up to get full access to all the novavax.com emails we have.
Find emails for Novavax, Inc executives, including the Chief Executive Officer, Chief Financial Officer, and Chief Marketing Officer.
Note: Only company contact information will be added. To discover and add individual contacts to My Prospects, please click though to the Company Profile page.